Patents Assigned to Lucas Meyer Cosmetics Canada Inc.
  • Patent number: 11752168
    Abstract: A skin care composition is disclosed comprising at least one exopolysaccharide (EPS) originating from a microbial mat, the EPS being in a concentration of about 0.001% w/w to about 1.5% w/w of the composition. Uses and methods of use thereof. In specific embodiments, the EPSs are derived from microorganisms isolated from microbial mats found in French Polynesia. The composition is useful in reducing signs of skin aging and environmental damage by altering skin cell metabolism and improving hydration.
    Type: Grant
    Filed: May 12, 2021
    Date of Patent: September 12, 2023
    Assignee: LUCAS MEYER COSMETICS CANADA INC.
    Inventors: Estelle Loing, Sandrine Briatte, Patrice Dionne, Martin Beaulieu, Xavier Moppert, Laurent Richert, Catherine Vayssier
  • Patent number: 11040058
    Abstract: A skin care composition is disclosed comprising at least one exopolysaccharide (EPS) originating from a microbial mat, the EPS being in a concentration of about 0.001% w/w to about 1.5% w/w of the composition. Uses and methods of use thereof. In specific embodiments, the EPSs are derived from microorganisms isolated from microbial mats found in French Polynesia. The composition is useful in reducing signs of skin aging and environmental damage by altering skin cell metabolism and improving hydration.
    Type: Grant
    Filed: May 14, 2018
    Date of Patent: June 22, 2021
    Assignee: Lucas Meyer Cosmetics Canada Inc.
    Inventors: Estelle Loing, Sandrine Briatte, Catherine Vayssier, Martin Beaulieu, Patrice Dionne, Laurent Richert, Xavier Moppert
  • Patent number: 10004678
    Abstract: An anti-dandruff composition comprising an Epilobium angustifolium extract, methods of use thereof and kits using same.
    Type: Grant
    Filed: August 21, 2014
    Date of Patent: June 26, 2018
    Assignee: Lucas Meyer Cosmetics Canada Inc.
    Inventor: Estelle Loing
  • Publication number: 20160184216
    Abstract: An anti-dandruff composition comprising an Epilobium angustifolium extract, methods of use thereof and kits using same.
    Type: Application
    Filed: August 21, 2014
    Publication date: June 30, 2016
    Applicant: LUCAS MEYER COSMETICS CANADA INC.
    Inventor: Estelle Loing
  • Patent number: 9364508
    Abstract: Provided is a plant derived extract including inhibitory activity against one or more extracellular proteases which degrade human tissue matrix. Moreover, the amount of inhibitory activity in an extract can be increased by stressing the plant prior to forming an extract. These extracts are each prepared by a process and demonstrate the ability to inhibit one or more extracellular proteases which degrade human tissue matrix. Libraries of extracts can be prepared from stressed and non-stressed plants, where each of the extracts demonstrate inhibitory activity against on or more extracellular protease inhibitors. Alternatively, semi-purified and purified inhibitory compounds can be isolated from the extracts. In one aspect, these extracts with inhibitory activity can be used during protein purification to minimize degradation due to extracellular proteases.
    Type: Grant
    Filed: March 20, 2014
    Date of Patent: June 14, 2016
    Assignee: LUCAS MEYER COSMETICS CANADA INC.
    Inventor: Benoit Cyr
  • Patent number: 9115176
    Abstract: A compound of the formula I: R-A-Gly-His-B (I) wherein: A and B are independently of each other a L-lysine residue, a D-lysine residue, or a L- or D-lysine residue in which the NH2 group of the side chain comprises a modification, where-in said modification is (i) a replacement with a hydrogen, (ii) an acetylation, (iii) a benzoylation, or (iv) a palmitoylation; GIy is a glycine residue; His is a L- or D-histidine residue; R is CH3—(CH2)n—CO—, wherein n=2, 3, 4, 5, 6, 7 or 8; R? is a group of formula (II): N(Z)(Z?) (II) wherein: Z and Z? is hydrogen, a methyl group, an ethyl group, a phenyl group, an hexyl group, a decyl group or an hexadecyl group; or a racemate, an enantiomer or a diastereomer thereof, or mixtures thereof, or a salt thereof.
    Type: Grant
    Filed: June 30, 2008
    Date of Patent: August 25, 2015
    Assignee: Lucas Meyer Cosmetics Canada Inc.
    Inventors: Michel Hocquaux, Estelle Loing, Philippe Bedos
  • Publication number: 20130190269
    Abstract: A method for inhibiting the release of one or more of IL-8, PGE2 and VEGF by a cell activated during an inflammatory process, said method comprising administering to said cell an anti-inflammatory polysaccharide composition comprising fucans and galactans to a cell, wherein the ratio of fucans to galactans in said composition enables a reduction in the cytotoxicity of said galactans and an anti-inflammatory composition comprising a ratio of brown algae fucans/red algae galactans of ranging from about 2.5/1 (w/w) to about 40/1 (w/w), the galactans having a molecular weight higher than about 100 kDa, and the fucans having a molecular weight ranging from about 0.1 kDa and 100 kDa.
    Type: Application
    Filed: March 12, 2013
    Publication date: July 25, 2013
    Applicant: LUCAS MEYER COSMETICS CANADA INC.
    Inventor: Lucas Meyer Cosmetics Canada Inc.
  • Patent number: 8426381
    Abstract: A use of an anti-inflammatory polysaccharides composition comprising fucans and galactans to inhibit the release of one or more of IL-8, PGE2 and VEGF by a cell activated during an inflammatory process and an anti-inflammatory composition comprising a ratio of brown algae fucans/red algae galactans of between about 2.5/1 (w/w) to about 40/1 (w/w), the galactans having a molecular weight higher than about 100 kDa, and the fucans having a molecular weight between about 0.1 kDa and 100 kDa.
    Type: Grant
    Filed: September 11, 2006
    Date of Patent: April 23, 2013
    Assignee: Lucas Meyer Cosmetics Canada Inc.
    Inventors: Alain Thibodeau, Alain Lavoie, Patrice Dionne, Jean-Yves Moigne